Global Bridges at Mayo Clinic and Pfizer Global Medical Grants Quality Improvement Request for Proposals (RFP) Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis

Funding Agency:
Pfizer Inc.

Amyloidosis is often misdiagnosed. For example, it is estimated that the correct diagnosis of TTR amyloidosis is delayed by years, in part because it is a multisystemic disorder. Our goal is to help accelerate this patient journey by supporting capacity building programs.

In recent years, Global Bridges at Mayo Clinic and Pfizer Global Medical Grants have supported independent projects focused on raising awareness and closing knowledge gaps to reduce the time it takes for patients to be correctly diagnosed and make treatment more accessible, while supporting the development of a global network of TTR amyloidosis experts.  Expanding the community of practice will help decrease the distance patients need to travel to be diagnosed, although valuable guidance may still be obtained from experienced centers further from home. This RFP is a continuation of this program.  

It is not our intent to support research projects. Any research projects will be considered out of scope for this project. Examples of out-of-scope projects include clinical research projects, basic science research, prevalence studies, registry development, health services research and outcomes research. 

Full Proposal Deadline: May 2, 2024

Agency Website

Eligibility Requirements

Geographic Scope: Global (not including the United States) 

Applications are invited from institutions, organizations or associations, e.g. professional schools, hospitals, healthcare systems, universities, patient advocacy groups, professional associations, government agencies 

Grants can only be awarded to organizations, not individuals or medical practice groups.

Amount Description

Total funding available for this RFP is US $225,000.  We anticipate funding 3 projects. 

Funding Type





Curriculum Development
International Opportunities
Medical - Clinical Science

External Deadline

May 2, 2024